Comments
Indoco Remedies witnessed a 0.40 per cent increase in its share price after the company announced receipt of EU GMP certification for its Baddi manufacturing facility.
The certification confirms compliance with reasonable manufacturing practice requirements per the EC Directive. The EU GMP certification will enable Indoco Remedies to supply drug products to Europe and other regions from the Baddi site, further enhancing the company’s capability to provide quality and affordable medicines.
The share price went up by 0.40 per cent to ₹324 at 11:16 a.m. on BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.